Top Markets
Coin of the day
Nutra Pharma Corp. Nutra Pharma Corp.

Nutra Pharma Corp.

NPHC
Rang în acțiuni #38963
Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in... Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in obtaining, licensing, and bringing to market a variety of pharmaceutical products, cutting-edge technologies, and both homeopathic and ethical medications. The company primarily targets the U.S. market, focusing its efforts on managing conditions such as pain, neurological ailments, cancer, autoimmune diseases, and infectious diseases. Its current commercial offerings include: Nyloxin and Nyloxin Extra Strength: These products are distributed as an oral spray for alleviating lower back pain, migraines, neck and shoulder discomfort, cramps, and neuropathic pain, and as a topical gel to relieve joint pain, arthritis, and repetitive stress injuries. Pet Pain-Away: An over-the-counter (OTC) homeopathic, non-narcotic, and non-addictive solution for chronic pain in household pets. Luxury Feet: An OTC pain reliever and anti-inflammatory designed to ease foot pain or discomfort specifically caused by high heels and stilettos. Nyloxin Military Strength: A specialized formulation for pain relief aimed at the United States Military and Veteran's Administration. Equine Pain-Away: An OTC topical pain management product for horses. Beyond its existing portfolio, Nutra Pharma Corp. is also advancing several pipeline candidates: RPI-78M: In development to treat neurological conditions such as multiple sclerosis, adrenomyeloneuropathy, and amyotrophic lateral sclerosis, alongside autoimmune diseases like rheumatoid arthritis and myasthenia gravis. RPI-MN: Under investigation for viral diseases, including human immunodeficiency virus (HIV/AIDS) and herpes, as well as for general antiviral applications. RPI-78: Being developed for applications in pain and arthritis. RPI-70: Also in development for pain relief. Founded in 2000, the company is headquartered in Plantation, Florida.
Preț acțiune
$0.0001
Ultima sincronizare: 2026-08-13
Capitalizare de piață
$715.97K
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-50.00%
Țară
US
Tranzacționează Nutra Pharma Corp. (NPHC)

Categorie

Prețul NPHC cu capitalizarea de piață a B
Nutra Pharma Corp. Nutra Pharma Corp.
NPHC
$0.0001
Capitalizarea de piață a Nutra Pharma Corp.(NPHC)
Capitalizare de piață: $715.97K
În anul August 2026, Nutra Pharma Corp. are o capitalizare de piață de $715.97K. Acest lucru face ca Nutra Pharma Corp. să fie a 38963rd-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Nutra Pharma Corp. din 2001 până în 2026
NPHC în comparație cu top 5 cele mai populare stocks
Prețul pentru NPHC Activul B Capitalizarea de piață a B Rezultate
Nutra Pharma Corp. Nutra Pharma Corp.
$763.93 $715.97K
$5.470T +763,930,631.75%
Nutra Pharma Corp. Nutra Pharma Corp.
$623.92 $715.97K
$4.467T +623,916,053.72%
Nutra Pharma Corp. Nutra Pharma Corp.
$583.04 $715.97K
$4.174T +583,036,741.67%
Nutra Pharma Corp. Nutra Pharma Corp.
$516.79 $715.97K
$3.700T +516,789,961.85%
Nutra Pharma Corp. Nutra Pharma Corp.
$398.67 $715.97K
$2.854T +398,666,148.52%